DIFFUSE CUTANEOUS MASTOCYTOSIS

This adverse event was reported 30 times

DIFFUSE CUTANEOUS MASTOCYTOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EQUINE THYMOCYTE IMMUNE GLOBULIN 5 0.0048
1 DEXCHLORPHENIRAMINE MALEATE 2 0.0020
2 VANCOMYCIN HYDROCHLORIDE 13 0.0016
3 ZAFIRLUKAST 1 0.0011
4 CROMOLYN SODIUM 2 0.0005
5 IMIPENEM AND CILASTATIN SODIUM 1 0.0005
6 CEFIXIME 1 0.0003
7 POSACONAZOLE 5 0.0003
8 CEFEPIME HYDROCHLORIDE 4 0.0002
9 HEPARIN SODIUM 3 0.0002
See all drugs enriched for association with DIFFUSE CUTANEOUS MASTOCYTOSIS